Gene Therapy Weekly
Susan Hasty, Publisher
Table of Contents . . . October 2nd, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Stem-Cell Research - A novel technique enhances embryonic and neuronal stem-cell labeling
Virology - Recombinant adeno-associated virus serotype 1 vectors can transduce nerve cells
Angiology - Polymer-coated stents offer a way to delivery gene therapy to immune cells
Gene Transfer - Cancer cells undergo self destruction with inducible caspase treatment
Neuroscience - Ex vivo neurotrophin gene transfer improves recovery from spinal cord injury
Vector Development - The SV40 enhancer augments nonviral gene delivery
Antisense Technology - Process helps achieve largest antisense oligonucleotide synthesis scale per run
Cancer Research - New nontumorigenic prostatic cells will advance cancer investigations
Dermatology - VEGF suppression decreases head and neck cancer angiogenesis
Diagnostic Imaging - Micro-PET is expected to advance medical research and clinical analysis
Drug Resistance - Activated transcription factor c-Jun inhibits multidrug resistance gene-1
Gastroenterology - E1 double-restricted adenovirus treats gallbladder cancer
Gene Therapy - HSV-1 vectors may raise oncogenesis risk
Gene Therapy - Lengthened targeting arms do not increase HR efficiency in stem-cell beta-globin locus
Gene Therapy - The strict-late viral promoter UL38p facilitates herpes simplex virus oncolysis
Gene Therapy Toxicity - "Stop leak" solution found for problems in experiments with mice
Gene Transfer - Coated stents deliver gene therapy to specific locales
HIV Therapy - Phase I trial of autologous VRX496 modified T cells deemed safe
Heart Block - Can we make a new sinus node?
Hematology - Negative selection augments the characterization of bone marrow derivatives
Immunology - CpG motifs can be programmed to stimulate specific immune system activities
Immunotherapy - Divergent virology can affect the outcome of ex vivo T-cell expansion
Lung Cancer - Data published showing effectiveness of DNA enzyme expression technology
Metastatic Cancer - Company gets patents for TNFerade and TNF product candidates targeting
Neurosicence - Gene therapy may prevail in the fight to cure neurological diseases
Patents - U.S. patent granted covering technologies directed to microbial enrichment
Prostate Cancer - Calpain-2 could be targeted to prevent malignant tumor invasion
Proteomics - Antisense DNA plasmids target enzyme to disable cytokine-driven inhibition
RNA Research - Hairpin RNAs and retrotransposon LTRs can mediate RNAi-, chromatin-based gene silencing
Transgenics - FISH and SKY analysis should be used to ensure genome stability in transgenic mice
Tumor Diagnosis - Technitium-99m probes provide an important way to image tumor gene expression
Vaccine Development - Production of recombinant botulinum protein vaccine candidate reported
Vector Development - Recombinant chemokine gene therapy diminishes tumor growth
Viral Genomics - Evolutionary adaptation enabled Tupaia adenovirus to expand host potential
Virology - Encapsulated Semliki Forest virus shows promise for tumor targeting
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
